237424-17-8 Purity
---
If you have any other questions or need other size, please get a quote.
Specification
Reference: [1] Journal of Organometallic Chemistry, 1999, vol. 581, # 1-2, p. 82 - 86
Reference: [1] Journal of Organometallic Chemistry, 1999, vol. 581, # 1-2, p. 82 - 86
Reference: [1]Current Patent Assignee: DALIAN SHUANGPENG PHARMACY CHEMICAL IND - CN114057782, 2022, A
Location in patent: Paragraph 0030; 0033-0034
Reference: [1] Journal of Organometallic Chemistry, 1999, vol. 581, # 1-2, p. 82 - 86
[2] Journal of Organometallic Chemistry, 1999, vol. 581, # 1-2, p. 82 - 86
Reference: [1]Current Patent Assignee: VERTEX PHARMACEUTICALS (OLD) - WO2007/56341, 2007, A1
Location in patent: Page/Page column 149-150
[2]Current Patent Assignee: VERTEX PHARMACEUTICALS (OLD) - US2008/9524, 2008, A1
Location in patent: Page/Page column 400; 401
[3]Current Patent Assignee: VERTEX PHARMACEUTICALS (OLD) - US2011/98311, 2011, A1
[4]Current Patent Assignee: VERTEX PHARMACEUTICALS (OLD) - US2015/231142, 2015, A1
Location in patent: Paragraph 1213
Reference: [1]Angewandte Chemie - International Edition,2020,vol. 59,p. 14671 - 14676
Angew. Chem.,2020,vol. 132,p. 14779 - 14784,6
* For details of the synthesis route, please refer to the original source to ensure accuracy.